Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 23 of about 9 companies and 14 funds for Gene Douglas�
Company Exchange Symbol Last price Quote change Market cap
Qiagen NV NASDAQ QGEN 21.92 +0.60 (2.81%) 5.31B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
GenVec Inc NASDAQ GNVC 1.68 -0.05 (-2.89%) 29.01M
GenVec, Inc. develops gene-based pharmaceuticals and therapies for the treatment of major medical needs. The Company combines its patented gene transfer ...
Precision Drilling Corp (USA) NYSE PDS 8.78 +0.08 (0.92%) 2.57B
Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas ...
Executive:
Gene C. Stahl
Precision Drilling Corporation TSE PD 9.89 +0.10 (1.02%) 2.89B
Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas ...
Executive:
Gene C. Stahl
Applied Micro Circuits Corporation NASDAQ AMCC 6.67 -0.21 (-3.05%) 521.56M
The Company's products include the X-Gene ARM 64 bit Server on a Chip solution, along with the X-WeaveTM family of connectivity products, ...
Qiagen NV ETR QIA 17.31 4.16B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
Qiagen NV FRA QIA 17.33 4.16B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
Assurant, Inc. NYSE AIZ 62.32 +0.66 (1.07%) 4.45B
Assurant, Inc. (Assurant) is a provider of specialized insurance products and related services in North America and select worldwide markets.
Executive:
Gene E. Mergelmeyer
Critical Outcome Technologies Inc. CVE COT 0.270 0.000 (0.00%) 28.01M
Critical Outcome Technologies Inc. (COTI) is a biotechnology company focused on applying its computer-based technology, CHEMSAS, to identify, profile, ...
Executive:
Gene Kelly
Mutual Fund Symbol Nav Nav change
American Beacon Small Cap Value Fund Class Institutional AVFIX 25.80 +0.04 (0.16%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Investor Class AVPAX 25.02 +0.03 (0.12%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Investor Class AAEPX 11.88 +0.13 (1.11%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class AMR AAMRX 12.20 +0.13 (1.08%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class A AEMAX 11.88 +0.13 (1.11%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Advisor Class AASSX 24.78 +0.04 (0.16%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class Y ABSYX 25.54 +0.03 (0.12%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class A ABSAX 24.71 +0.03 (0.12%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class AMR AASVX 25.74 +0.03 (0.12%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Institutional AEMFX 12.09 +0.12 (1.00%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund C Class AEMCX 11.76 +0.13 (1.12%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Y ACEYX 12.15 +0.13 (1.08%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class R ASCVX 24.31 +0.03 (0.12%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund C Class ASVCX 24.18 +0.03 (0.12%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.